Ronald G. Tilton

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

Thomas P. Misko, William M. Moore, Thomas P. Kasten et al. · European Journal of Pharmacology · 1993 · 724 citations

Selective Inhibition, Molecular Pharmacology, Biochemistry +7

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

John A. Corbett, Ronald G. Tilton, Kathy Chang et al. · Diabetes · 1992 · 609 citations · Full text

An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice

Brian Tieu, Chang Lee, Hong Sun et al. · Journal of Clinical Investigation · 2009 · 446 citations · Full text

Inflammation, Cytokine, Inflammatory Disease +15

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes

An S. De Vriese, Ronald G. Tilton, Marlies Elger et al. · Journal of the American Society of Nephrology · 2001 · 442 citations

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

Anne H. Cross, Thomas P. Misko, R F Lin et al. · Journal of Clinical Investigation · 1994 · 383 citations · Full text

Prime Model, Neurological Disorder, Nitric Oxide +18